Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$25,463,032
+$2,911,732 QoQ
Shares Held
100,260
+8.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#651
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Dec 31, 2020CallValue
$2,045
CallShares
13
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Independent Advisor Alliance holds $142,543,101 across 14 Drug Manufacturers - General names. JNJ ranks #2 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
41,149 | $49,355,348 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
100,260 | $25,463,032 | |
| 3 | ABBV |
AbbVie Inc.
|
91,394 | $22,998,385 | |
| 4 | MRK |
Merck & Co., Inc.
|
102,748 | $13,203,117 | |
| 5 | AMGN |
Amgen Inc
|
30,517 | $11,050,815 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
97,475 | $5,616,509 | |
| 7 | PFE |
Pfizer Inc
|
223,046 | $5,370,947 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
38,289 | $4,837,431 |
All Filings in JNJ
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,463,032 | 100,260 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $22,551,300 | 92,257 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $20,810,892 | 100,560 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $18,633,782 | 100,495 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $14,342,919 | 93,898 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $15,925,448 | 96,029 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $13,519,221 | 93,481 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $14,256,742 | 87,972 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,571,913 | 113,382 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $22,236,135 | 140,566 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $23,593,915 | 150,529 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $23,622,446 | 151,669 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $25,380,340 | 153,337 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $23,561,550 | 152,010 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $28,483,929 | 161,245 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $25,384,673 | 155,391 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $28,976,731 | 163,240 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $27,316,637 | 154,131 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $26,981,502 | 157,722 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $25,082,888 | 155,312 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $24,888,424 | 151,077 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $26,792,829 | 163,023 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,045 | 13 | Call | Sole | 2021-02-11 | |
| 2020-12-31 | $21,914,063 | 139,243 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $19,180,210 | 128,830 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $13,002,649 | 92,460 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $12,381,425 | 94,421 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||